DE HB331

Adds definitions for "benzodiazepine" (drugs like alprazolam, clonazepam, diazepam, lorazepam, and temazepam that depress the central nervous system) and "non-benzodiazepine hypnotic" (zaleplon, zolpidem, and similar Schedule II or III controlled substances) to Title 16 of Delaware Code.

Requires the Secretary of the Department of Health and Social Services to produce and distribute pamphlets to pharmacies containing consumer education about benzodiazepines and non-benzodiazepine hypnotics, including information on misuse, abuse, dependency risks, proper storage and disposal, and treatment resources.

Mandates pharmacists distribute the educational pamphlet when dispensing benzodiazepines or non-benzodiazepine hypnotics.

Prohibits practitioners from prescribing benzodiazepines or non-benzodiazepine hypnotics to minors without first obtaining written informed consent from a parent or guardian, except in emergency treatment or for treatment of neuromuscular disabilities.

Requires the Secretary to create a standardized consent form for practitioners that explains in lay terms the risks of misuse, abuse, dependency, addiction, life-threatening risks for first-time use, and long-term use complications.